Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 2Glioblastoma 2Stomach Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Mycosis Fungoides 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Head and Neck Carcinoma of Unknown Primary 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 2Methotrexate 2fluorodopa F 18 1etoposide phosphate 1Temozolomide 1Radiation 1Perfusion Magnetic Resonance Imaging 1Magnetic Resonance Spectroscopy 1Leucovorin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gadolinium DTPA 1Etoposide 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Diffusion Magnetic Resonance Imaging 1Biopsy 1Azacitidine 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Ependymoma × Radiation × Clear all
NCT01165632 2025-09-02

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Mayo Clinic

Phase EARLY_PHASE1 Completed
24 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡